TY - JOUR
T1 - Trifecta Outcomes of Partial Nephrectomy in Patients Over 75 Years Old
T2 - Analysis of the REnal SURGery in Elderly (RESURGE) Group
AU - Bindayi, Ahmet
AU - Autorino, Riccardo
AU - Capitanio, Umberto
AU - Pavan, Nicola
AU - Mir, Maria Carmen
AU - Antonelli, Alessandro
AU - Takagi, Toshio
AU - Bertolo, Riccardo
AU - Maurer, Tobias
AU - Ho Rha, Koon
AU - Long, Jean−Alexandre A.
AU - Yang, Bo
AU - Schips, Luigi
AU - Lima, Estevão
AU - Breda, Alberto
AU - Linares, Estefania
AU - Celia, Antonio
AU - De Nunzio, Cosimo
AU - Dobbs, Ryan
AU - Patel, Sunil
AU - Hamilton, Zachary
AU - Tracey, Andrew
AU - Larcher, Alessandro
AU - Trombetta, Carlo
AU - Palumbo, Carlotta
AU - Tanabe, Kazunari
AU - Amiel, Thomas
AU - Raheem, Ali
AU - Fiard, Gaelle
AU - Zhang, Chao
AU - Castellucci, Roberto
AU - Palou, Joan
AU - Ryan, Stephen
AU - Crivellaro, Simone
AU - Montorsi, Francesco
AU - Porpiglia, Francesco
AU - Derweesh, Ithaar H.
N1 - Publisher Copyright:
© 2019
PY - 2020/9/15
Y1 - 2020/9/15
N2 - Background: Partial nephrectomy (PN) in elderly patients is underutilized with concerns regarding risk of complications and potential for poor outcomes. Objective: To evaluate quality and functional outcomes of PN in patients >75 yr using trifecta as a composite outcome of surgical quality. Design, setting, and participants: Multicenter retrospective analysis of 653 patients aged >75 yr who underwent PN (REnal SURGery in Elderly [RESURGE] Group). Intervention: PN. Outcome measurements and statistical analysis: Primary outcome was achievement of trifecta (negative margin, no major [Clavien ≥3] urological complications, and ≥90% estimated glomerular filtration rate [eGFR] recovery). Secondary outcomes included chronic kidney disease (CKD) stage III and CKD upstaging. Multivariable analysis (MVA) was used to assess variables for achieving trifecta and functional outcomes. Kaplan-Meier survival analysis (KMA) was used to calculate renal functional outcomes. Results and limitations: We analyzed 653 patients (mean age 78.4 yr, median follow-up 33 mo; 382 open, 157 laparoscopic, and 114 robotic). Trifecta rate was 40.4% (n = 264). Trifecta patients had less transfusion (p < 0.001), lower intraoperative (5.3% vs 27%, p < 0.001) and postoperative (25.4% vs 37.8%, p = 0.001) complications, shorter hospital stay (p = 0.045), and lower ΔeGFR (p < 0.001). MVA for predictive factors for trifecta revealed decreasing RENAL nephrometry score (odds ratio [OR] 1.26, 95% confidence interval 1.07–1.51, p = 0.007) as being associated with increased likelihood to achieve trifecta. Achievement of trifecta was associated with decreased risk of CKD upstaging (OR 0.47, 95% confidence interval 0.32–0.62, p < 0.001). KMA showed that trifecta patients had improved 5-yr freedom from CKD stage 3 (93.5% vs 57.7%, p < 0.001) and CKD upstaging (84.3% vs 8.2%, p < 0.001). Limitations include retrospective design. Conclusions: PN in elderly patients can be performed with acceptable quality outcomes. Trifecta was associated with decreased tumor complexity and improved functional preservation. Patient summary: We looked at quality outcomes after partial nephrectomy in elderly patients. Acceptable quality outcomes were achieved, measured by a composite outcome called trifecta, whose achievement was associated with improved kidney functional preservation.
AB - Background: Partial nephrectomy (PN) in elderly patients is underutilized with concerns regarding risk of complications and potential for poor outcomes. Objective: To evaluate quality and functional outcomes of PN in patients >75 yr using trifecta as a composite outcome of surgical quality. Design, setting, and participants: Multicenter retrospective analysis of 653 patients aged >75 yr who underwent PN (REnal SURGery in Elderly [RESURGE] Group). Intervention: PN. Outcome measurements and statistical analysis: Primary outcome was achievement of trifecta (negative margin, no major [Clavien ≥3] urological complications, and ≥90% estimated glomerular filtration rate [eGFR] recovery). Secondary outcomes included chronic kidney disease (CKD) stage III and CKD upstaging. Multivariable analysis (MVA) was used to assess variables for achieving trifecta and functional outcomes. Kaplan-Meier survival analysis (KMA) was used to calculate renal functional outcomes. Results and limitations: We analyzed 653 patients (mean age 78.4 yr, median follow-up 33 mo; 382 open, 157 laparoscopic, and 114 robotic). Trifecta rate was 40.4% (n = 264). Trifecta patients had less transfusion (p < 0.001), lower intraoperative (5.3% vs 27%, p < 0.001) and postoperative (25.4% vs 37.8%, p = 0.001) complications, shorter hospital stay (p = 0.045), and lower ΔeGFR (p < 0.001). MVA for predictive factors for trifecta revealed decreasing RENAL nephrometry score (odds ratio [OR] 1.26, 95% confidence interval 1.07–1.51, p = 0.007) as being associated with increased likelihood to achieve trifecta. Achievement of trifecta was associated with decreased risk of CKD upstaging (OR 0.47, 95% confidence interval 0.32–0.62, p < 0.001). KMA showed that trifecta patients had improved 5-yr freedom from CKD stage 3 (93.5% vs 57.7%, p < 0.001) and CKD upstaging (84.3% vs 8.2%, p < 0.001). Limitations include retrospective design. Conclusions: PN in elderly patients can be performed with acceptable quality outcomes. Trifecta was associated with decreased tumor complexity and improved functional preservation. Patient summary: We looked at quality outcomes after partial nephrectomy in elderly patients. Acceptable quality outcomes were achieved, measured by a composite outcome called trifecta, whose achievement was associated with improved kidney functional preservation.
KW - Carcinoma
KW - Chronic Kidney Disease
KW - Elderly
KW - Outcome Assessment
KW - Partial Nephrectomy
KW - Renal Cell
KW - Trifecta
KW - Carcinoma
KW - Chronic Kidney Disease
KW - Elderly
KW - Outcome Assessment
KW - Partial Nephrectomy
KW - Renal Cell
KW - Trifecta
KW - Carcinoma
KW - Chronic Kidney Disease
KW - Elderly
KW - Outcome Assessment
KW - Partial Nephrectomy
KW - Renal Cell
KW - Trifecta
UR - http://www.scopus.com/inward/record.url?scp=85061771309&partnerID=8YFLogxK
U2 - 10.1016/j.euf.2019.02.010
DO - 10.1016/j.euf.2019.02.010
M3 - Article
C2 - 30799289
AN - SCOPUS:85061771309
SN - 2405-4569
VL - 6
SP - 982
EP - 990
JO - European Urology Focus
JF - European Urology Focus
IS - 5
ER -